skip to Main Content

Surgery is a Viable Treatment for Pancreatic Cancer Patients Especially after Chemotherapy

Newsfeed image, light gray text on dark gray background
Patients with stage II pancreatic cancer who are treated with chemotherapy followed by resection (an operation that removes the cancerous part of the organ, structure or tissue) live nearly twice as long as patients who receive only chemotherapy, according to a new Journal of the American College of Surgeons study published online in advance of print.

In stage II patients, there is a chance that pancreatic cancer can be removed by resection even after it has spread close to blood vessels. Although chemotherapy can improve outcomes, the risk of surgery is justified because the patients live longer even if the cancerous tissue is not entirely removed, according to the study from researchers at the University of Arizona Department of Surgery, Tucson. Read more . . . 

Back To Top